Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,010,154 papers from all fields of science
Search
Sign In
Create Free Account
DMP 696
Known as:
4-(1,3-dimethoxy-2-propylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)(1,5-a)pyrazolo-1,3,5-triazine
, DMP-696
, DMP696
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Pyrazoles
Triazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus
C. Thoeringer
,
K. Henes
,
+6 authors
C. Wotjak
Neuropsychopharmacology
2012
Corpus ID: 20614465
Persistent dreadful memories and hyperarousal constitute prominent psychopathological features of posttraumatic stress disorder…
Expand
Highly Cited
2007
Highly Cited
2007
Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence
Mathias V. Schmidt
,
V. Sterlemann
,
+7 authors
Marianne B. Müller
Psychoneuroendocrinology
2007
Corpus ID: 41620255
Highly Cited
2007
Highly Cited
2007
Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear
D. Hubbard
,
B. R. Nakashima
,
I. Lee
,
L. Takahashi
Neuroscience
2007
Corpus ID: 629652
Review
2006
Review
2006
The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists.
Yu-Wen Li
,
L. Fitzgerald
,
+8 authors
R. Zaczek
CNS drug reviews
2006
Corpus ID: 45453457
CRF(1) antagonists DMP696 and DMP904 were designed as drug development candidates for the treatment of anxiety and depression…
Expand
Highly Cited
2006
Highly Cited
2006
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists
L. Carboni
,
M. Vighini
,
C. Piubelli
,
L. Castelletti
,
A. Milli
,
E. Domenici
European Neuropsychopharmacology
2006
Corpus ID: 32598738
Review
2006
Review
2006
Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics.
C. Chen
Current Medicinal Chemistry
2006
Corpus ID: 11395902
Corticotropin-releasing factor (CRF), a 41-amino acid peptide, has been recognized as an important factor mediating stress…
Expand
2004
2004
Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats
B. Campbell
,
J. Morrison
,
E. L. Walker
,
K. Merchant
Pharmacology, Biochemistry and Behavior
2004
Corpus ID: 29365016
Highly Cited
2003
Highly Cited
2003
Receptor Occupancy of Nonpeptide Corticotropin-Releasing Factor 1 Antagonist DMP696: Correlation with Drug Exposure and Anxiolytic Efficacy
Yu-Wen Li
,
Geraldine Hill
,
+10 authors
Robert Zazcek
Journal of Pharmacology and Experimental…
2003
Corpus ID: 1268754
4-(1,3-Dimethoxyprop-2-ylamine)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine (DMP696) is a highly selective…
Expand
Highly Cited
2002
Highly Cited
2002
Effects of a Non-peptide CRF Antagonist (DMP696) on the Behavioral and Endocrine Sequelae of Maternal Separation
C. Maciag
,
G. Dent
,
+5 authors
Mark A. Smith
Neuropsychopharmacology
2002
Corpus ID: 22719850
2002
2002
The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats
J. McElroy
,
Kathryn A. Ward
,
+4 authors
S. Lelas
Psychopharmacology
2002
Corpus ID: 12481865
Abstract Rationale. CRF1 antagonists may be effective in the treatment of anxiety disorders while having fewer side effects…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE